Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease. A 16-Week randomized, double-blind, placebo-controlled study

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions